NEWARK, Del, Dec. 14, 2023 (GLOBE NEWSWIRE) -- As per the recent research report by Future Market Insights (FMI), a research and competitive intelligence provider, the nootropic supplement market size is estimated to reach US$ 4,180 million by 2033, surging at 9.0% CAGR by 2033.
The growing popularity of consumers wanting robust brain health resulted in high demand in the nootropic supplement market. Increasing expenditure on memory supplements is another key factor driving market growth. Consumers across the globe are shifting their preferences towards supplements containing natural ingredients. This is creating lucrative growth opportunities for nootropic supplement manufacturers.
A nootropic supplement, or "smart drug," is a compound that presents high attractiveness to consumers who prefer more lasting mental activity and focus. Nootropics are used to treat diseases such as Alzheimer's since they offer numerous benefits for brain health and cognitive aptitude.
Request a Sample of this Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-18025
Primarily, this supplement is sold to consumers through two formats. One is through over-the-counter, where an individual has access to a range of nootropic supplements that do not require any prescription from a doctor or a professional. Conversely, the prescribed format refers to the nootropic supplement that can be accessed only after getting approval from a doctor or health professional.
According to a recent market report, 60% of global consumers plan to improve their health and wellness over the next year. This is expected to bode well for supplement demand globally. It also notes that 79% of United States consumers say that taking a supplement is vital to their overall health, 67% of global nutritional supplement users plan to continue using supplement over the next year, and 49% of all supplement users say they'd be willing to spend more on supplement.
Another important factor influencing the development of the nootropics supplement business is the increasing cost of healthcare, which aids in improving infrastructure. Increasing initiatives by private and public organizations to raise awareness will inflate. There is a rising awareness of cognitive well-being and a desire among individuals to improve mental performance. People are looking for ways to advance focus, memory, and inclusive brain purpose, leading to an increasing demand in the nootropic supplement market.
There is a rising trend towards self-improvement and individual health optimization in several aspects of life, comprising cognitive performance. Nootropic supplement is considered a tool to achieve these goals, aligning with wider self-optimization and wellness movements. A surge in research and development activities drives the growth. This will bring valuable opportunities for the expansion.
Consumers' desire for better brain health has resulted in the use of nootropic pills, and their global popularity has increased demand for them. Another significant reason driving growth in the global nootropics supplement industry is rising spending on memory supplements. Globally, consumers are shifting their preferences toward supplements containing natural components. This creates attractive expansion potential for manufacturers of nootropic substances.
"In the longer run, changing consumer preferences towards natural and herbal ingredients along with a willingness to spend more on premium nootropic supplement is projected to provide profitable opportunities for participants,” - Nandini Roy Choudhury, Client Partner at Future Market Insights
Key Takeaways from the Nootropic Supplement Report:
- The North American nootropic supplement industry is estimated to be valued at US$ 477.4 million by 2023.
- In North America, the United States holds the leading share of 93.0% of the nootropic supplement ecosystems.
- Based on type, natural ingredient type is expected to hold a share of 64.3% in 2023
- In East Asia, China holds the leading share of 56.7% of the nootropic supplement industry.
- The nootropic supplement business is projected to be worth US$ 4,180 million by 2033.
Competitive Landscape:
The business offers a wide range of products that provide individual and nootropics stacks (combinations of different nootropics) targeting brain health. Several companies have been engaged in the nootropics supplement business. Several established players and several medium and small-sized players categorize the segment. Product launches are key growth initiatives businesses undertake to gain a competitive advantage in the sales. Product manufacturers are presenting new variations in the nootropic product category to appeal to a broader customer base.
Key Companies Profiled:
- Onnit Labs
- Mental Mojo LLC
- NooCube
- Mind Lab Pro
- TruBrain
- Peak Nootropics
- Zhou Nutrition
- Kimera Koffee
- Neu Drink
- Accelerated Intelligence Inc
- AlternaScript LLC
- Cephalon Inc.
- SupNootropic Bio Co. Ltd.
- Teva Pharmaceutical Industries Ltd
- Nootrobox Inc.
For instance,
- Onnit is known for its Alpha Brain product, popular among athletes. Companies are investing in research and development to generate formulations targeting specific needs.
- In October 2021, Savvy Beverage plans to launch soft drinks and instant coffee comprising nootropic elements to improve brain health.
- In February 2021, Mind Cure Health Inc. announced the launch of its initial nootropic and Adaptogen products to promote care across the mental hygiene spectrum.
Purchase the Report for Key Insights: https://www.futuremarketinsights.com/checkout/18025
Get More Valuable Insights:
Future Market Insights (FMI), in its new offering, provides an unbiased analysis of the nootropic supplement, presenting historical demand data (2018 to 2022) and forecast statistics for the period from 2023 to 2033.
The study incorporates compelling insights on the nootropic supplement industry based on ingredient type (natural and synthetic), product category (over-the-counter and prescribed), form (capsules/tablets, powder, drinks, and gummy), distribution channel (health food stores, pharmacies and drugstores, professional healthcare practitioners, nutrition stores, healthcare professionals, and online retailers), and region.
Nootropic Supplement Segmentation by Category:
By Ingredient Type:
- Natural
- Panax Ginseng
- Ginkgo Biloba
- Asiatic Pennywort
- Ashwagandha
- Bacopa Monnieri
- Guarana
- Eleuthero
- Rhodiola Rosea
- Schisandra Chinensis
- Others (Maca, etc.)
- Synthetic
- Racetams
- Modafinil
- Sunifiram
- Phosphatidylserine
- Choline
- DMAE
- Unifiram
- Hydrafinil
- Citicoline
- Others (Adranfinil, etc.)
By Product Category:
- Prescribed
- Over-the-Counter
By Form:
- Capsules/Tablets
- Powder
- Drinks
- Gummy
By Distribution Channel:
- Health Food Stores
- Pharmacies and Drugstores
- Professional Healthcare Practitioners
- Nutrition Stores
- Healthcare Professionals
- Online Retailers
Authored by:
Nandini Roy Choudhury (Client Partner for Food & Beverages at Future Market Insights, Inc.) has 7+ years of management consulting experience. She advises industry leaders and explores off-the-eye opportunities and challenges. She puts processes and operating models in place to support their business objectives.
She has exceptional analytical skills and often brings thought leadership to the table.
Nandini has vast functional expertise in key niches, including but not limited to food ingredients, nutrition & health solutions, animal nutrition, and marine nutrients. She is also well-versed in the pharmaceuticals, biotechnology, retail, and chemical sectors, where she advises market participants to develop methodologies and strategies that deliver results.
Her core expertise lies in corporate growth strategy, sales and marketing effectiveness, acquisitions and post-merger integration and cost reduction. Nandini has an MBA in Finance from MIT School of Business. She also holds a Bachelor’s Degree in Electrical Engineering from Nagpur University, India.
Nandini has authored several publications, and quoted in journals including Beverage Industry, Bloomberg, and Wine Industry Advisor.
Explore FMI’s related ongoing Coverage in the Food and Beverage Domain:
Dietary Supplements Market Size is likely to exceed US$ 163.66 billion by 2033. The dietary supplements market players can anticipate a compelling CAGR of 9.1% through 2033.
Probiotic Supplements Market is estimated to be valued at US$ 7,078.1 million in 2023. It is anticipated to reach US$ 23,977.9 million in 2033. The market is expected to grow at an impressive CAGR of 13.0% from 2023 to 2033.
Digestive Health Supplements Market Size is estimated to reach US$ 17,160 million in 2023. With demand expanding at a 6% CAGR, the market size is projected to reach US$ 29,648.6 million over the forecast period.
Probiotics after Antibiotic Recovery Market is expected to expand from US$ 2,200 million in 2023 to US$ 4,180 million by 2033. From 2023 to 2033, global nootropic supplement sales are likely to soar at 9.0% CAGR.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vasat team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact FMI:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
